HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications.
Reversible acetylation mediated by histone deacetylases (HDACs) influences a broad repertoire of physiological processes, many of which are aberrantly controlled in tumor cells. As HDAC inhibition prompts tumor cells to enter apoptosis, small-molecule HDAC inhibitors have been developed as a new cla...
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|